Interaction between serum albumin and mercaptoundecahydrododecaborate ion (an agent for boron-neutron capture therapy of brain tumor). I. Introductory remarks and preliminary experiments.
- 31 December 1975
- journal article
- research article
- Published by Pharmaceutical Society of Japan in CHEMICAL & PHARMACEUTICAL BULLETIN
- Vol. 24 (12) , 2934-2941
- https://doi.org/10.1248/cpb.24.2934
Abstract
The interaction between bovine serum albumin and dodecahydrododecaborate B12H122- or mercaptoundecahydrododecaborate B12H11SH2- anion was investigated by equilibrium dialysis, equilibrium distribution in and out of a Sephadex gel, gel-filtration-, ion-exchange and ion-retardation-chromatographies. Both borates are strongly bound to the albumin through ion-pair formation with cationic sites on the protein molecules. This binding of ionic character can be readily broken up by ion-exchange or ion-retardation chromatography. The latter borate shows another mode of binding which is resistant against ion-exchange and ion-retardation resins. This binding of covalent character is due to the formation of disulfide linkage between the boron cage of B12H11SH2- and the albumin.This publication has 1 reference indexed in Scilit:
- Penetration of Brain and Brain Tumor. VII. Tumor-Binding Sulfhydryl Boron CompoundsJournal of Medicinal Chemistry, 1967